Hearing loss: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• NRF2 0
• MAPK 0
• NLRP3 0
• AMPK 0
• mTOR 0
• PI3K 0
• GLP-1 0
• AKT 0
• GPX4 0
• SIRT1 0
• TFEB 0
• TP53 0
• BDNF 0
• PD-1 0
• VEGF 2
• ERK 0
• JAK 0
• MMP-9 0
• PINK1 0
• SGLT2 0
• SHP2 0
• STAT3 0
• STING 0
• TNF 0
• YAP 0
• ABL1 0
• APOE 0
• CGRP 0
• COX-2 0
• CXCR4 0
• HDAC 0
• HIF-1 0
• HSP90 0
• IL-6 0
• METTL3 0
• NMDA 0
• NRAS 0
• PARP 0
• PDGFR 0
• PPAR 0
• PTEN 0
• TDP-43 0
• TLR4 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• U.S. Department of Veterans Affairs · I01

  Basic mechanisms in hearing loss of cochlear origin.

  Va San Diego Healthcare System· San Diego, Egyesült Államok· until 2030. szept.

• U.S. Department of Veterans Affairs · IK1

  Noise exposure-induced myelin degeneration in hearing impariment

  Ralph H Johnson Va Medical Center· Charleston, Egyesült Államok· until 2028. szept.

• NIH NIDCD · F31

  Utilizing Static Pressure in Wideband Tympanometry to Improve Automated Diagnosis of Hearing Loss Pathologies

  Harvard Medical School· Boston, Egyesült Államok· 38 253 USD awarded in fiscal year 2026· until 2028. szept.

• NIH NIDCD · F31

  Time-Domain Measurement and Modeling to Trace the Roles of Stochastic and Fast-Adaptive Outer-Hair-Cell Bundle Behavior in the Sensitive Cochlea

  Harvard Medical School· Boston, Egyesült Államok· 38 253 USD awarded in fiscal year 2026· until 2030. szept.

• NIH NIA · F30

  Improving Genomic-Informed Risk Assessment for Dementia with Mitochondrial Polygenic Scores

  University of Kansas Medical Center· Kansas City, Egyesült Államok· 41 884 USD awarded in fiscal year 2026· until 2030. szept.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE

  REstoring VIsion via native-Code-Aligned Neurostimulation (REVICAN)

  Univerzita Karlova· Praha 1, Csehország· EU contribution 731 460 EUR· until 2030. szept.· 9 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  Visual Hearing for Context-Aware Cognitive Audio Technology (WeHear)

  Danmarks Tekniske Universitet· Kongens Lyngby, Dánia· EU contribution 5 411 208 EUR· until 2029. aug.· 5 countries

• European Commission (Horizon Europe) · HORIZON-ERC

  Unlocking bio-inspired machine hearing and accelerating personalized hearing technologies (InSilicoEars)

  Universiteit Gent· Gent, Belgium· EU contribution 1 999 712 EUR· until 2031. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Watts in my ear? Unravelling the power source of mammalian hearing. (ActivEAR)

  Universidad Autonoma de Madrid· Madrid, Spanyolország· EU contribution 1 923 556 EUR· until 2031. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-CSA

  Advancing a scalable and multifactorial exosome therapy to address the unmet needs of drug-induced hearing loss (EXO-OTOProtect)

  Exogenus Therapeutics Sa· Cantanhede, Portugália· EU contribution 500 000 EUR· until 2028. febr.

10 of 741 running projects, newest first. Listed amounts together: 366,8 M USD + 41,9 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 4
• Organoids 12
• Mendelian Randomization Analysis 16
• CRISPR-Cas Systems 6
• Gene Expression Profiling 18
• Sequence Analysis, RNA 1
• Whole Genome Sequencing 6
• Exome Sequencing 75
• Proteomics 10
• Metabolomics 9
• Mass Spectrometry 1
• Immunohistochemistry 12
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 4
• Magnetic Resonance Imaging 162
• Machine Learning 37
• Deep Learning 20
• Cohort Studies 95
• Genome-Wide Association Study 23

• [Genetic analysis of a child with Frontometaphyseal dysplasia 1 due to variant of FLNA gene and literature review].

  Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2026. nov.

• Clinically isolated hearing loss as a mild phenotype of PEX26-associated peroxisomal biogenesis disorder: A case report, literature review, and in silico analysis.

  Mol Biol Rep, 2026. okt.

• Expanding the genetic landscape of MYO15A: Discovery of a novel splice-region variant in an Iranian family and insights into splicing variants.

  Hear Res, 2026. okt.

• Integrated genetic and functional analyses reveal the pathogenic effects of a novel STXBP3 variant in very-early-onset inflammatory bowel disease with immunodeficiency.

  Front Immunol, 2026. okt.

• Variants in CEP135 Cause Congenital Microcephaly and Primary Ciliary Dyskinesia.

  Pediatr Pulmonol, 2026. okt.

• Exome Sequencing Identifies Novel Variants Causing Hearing Loss in Three Consanguineous Pakistani Families: Insights From Genomics and Bioinformatics Analyses.

  Ann Hum Genet, 2026. szept.

• A Novel De Novo STAG1 Variant at the RAD21 Binding Interface Is Associated With Hypoglycemia, Recurrent Fever, Immunodeficiency and Features of Classical Cohesinopathies.

  Clin Genet, 2026. szept.

• Mutation Spectrum and Novel Rare Variants in a Han Chinese Hearing Loss Cohort Using a Tiered Sequencing Strategy.

  Mol Genet Genomic Med, 2026. szept.

• Whole exome sequencing of paediatric patients with Cogan's syndrome to identify monogenic mimics.

  Rheumatology (Oxford), 2026. szept.

• Whole Exome Sequencing Identified a Novel Mutation in the LOXHD1 Gene in Consanguineous Iranian Families With Hearing Loss.

  J Clin Lab Anal, 2026. aug.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.